3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Brain Neoplasms
1905
Glioblastoma
1797
Glioma
1130
Central Nervous System Neoplasms
599
Astrocytoma
594
Neuroblastoma
552
Gliosarcoma
465
Oligodendroglioma
364
Neoplasms
312
Breast Neoplasms
273
Medulloblastoma
272
Carcinoma, Non-Small-Cell Lung
227
Recurrence
199
Sarcoma
184
Neoplasm Metastasis
183
Melanoma
182
Meningioma
177
Ependymoma
176
Lung Neoplasms
157
Lymphoma
134
Osteosarcoma
127
Meningeal Carcinomatosis
126
Neurofibromatosis 1
114
Wilms Tumor
111
Ovarian Neoplasms
110
Diffuse Intrinsic Pontine Glioma
105
Precursor Cell Lymphoblastic Leukemia-Lymphoma
103
Rhabdomyosarcoma
101
Lymphoma, Non-Hodgkin
96
Burkitt Lymphoma
89
Interventions
Sirolimus
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Vestibulocochlear Nerve Diseases
×
CNS
×
Clear all
NCT04241679
2024-04-25
ANTS
Washington University School of Medicine
Phase NA
Completed
10 enrolled
NCT01490476
2017-05-23
AFINF2
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
10 enrolled